Hua R, Kong F, Wen X, Xiong Q, et al. Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection - an open-label, phase 2 study. J Viral Hepat 2022 Jan 26. doi: 10.1111/jvh.13650.
PMID: 35080256